Elevated serum phosphate levels have been linked with vascular calcification and mortality
among dialysis patients. The relationship between phosphate and mortality has not been …

Background and objectives: Higher phosphate is associated with mortality in dialysis
patients but few prospective studies assess this in nondialysis patients managed in an …

Within the normal range, higher serum phosphate concentrations are associated with
cardiovascular events and mortality in individuals with chronic kidney disease (CKD) and in …

Elevated serum phosphorus is a predictable accompaniment of end-stage renal disease
(ESRD) in the absence of dietary phosphate restriction or supplemental phosphate binders …

KDIGO guidelines recommend dietary phosphate restriction to lower serum phosphate
levels in CKD stages 3–5. Recent studies suggest that dietary phosphate intake is only …

Background: Severe hyperphosphatemia (serum phosphate level> 6.5 mg/dL [> 2.10
mmol/L]) has been associated directly with increased overall and cardiovascular mortality in …

Background. High serum phosphate has been identified as an important contributor to the
vascular calcification seen in patients with chronic kidney disease (Block et al., Am J Kidney …

Objective—Hyperphosphatemia is a cardiovascular risk factor in patients with chronic kidney
disease. Relations of circulating calcium (Ca) and phosphorus (Pi) to long-term mortality risk …

Background. Hyperphosphataemia is associated with increased mortality in patients with
chronic kidney disease (CKD) stage IV or on dialysis. Furthermore, in animal studies …

Results Older age and male sex were associated with lower phosphate levels. Instead,
higher phosphate levels were noted in patients with diabetes. Patients with phosphate …